Irbesartan in hypertension and type 2 diabetes with renal disease: the renoprotective effects - a consultant perspective

Anthony Barnett

Research output: Contribution to journalReview article

Original languageEnglish
Pages (from-to)pp4-6
JournalCardiabetes (Key paper review)
Publication statusPublished - 1 Jan 2002

Cite this